Unable to load price data. Sorry.

¯\_(ツ)_/¯

pSivida Limited (ADR) (NASDAQ:PSDV)

CAPS Rating: No stars

A drug delivery company focusing on the development of products utilizing its proprietary technologies for targeted and controlled drug delivery.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQ:PSDV will perform against the market?

Add Stock to CAPS Watchlist

All Players

58 Outperform
10 Underperform
 

All-Star Players

7 Outperform
4 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top NASDAQ:PSDV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted October 17, 2016

pSivida has fallen off a cliff since the last earnings call in August, probably because the timeline of regulatory submissions for Medidur has been pushed back once again. With a market cap of 80M and cash of 29M there's still room to fall so we… More

Ernbo6 (53.20)
Submitted May 15, 2007

Sivida Limited is engaged in the development and commercialization of drug delivery products in the healthcare sector, initially in ophthalmology and oncology. The principal activities of the Company and its subsidiaries during the fiscal year ended… More

NASDAQ:PSDV VS S&P 500 (SPY)

Fools bullish on NASDAQ:PSDV are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about PSDV.

Recs

1
Member Avatar zzlangerhans (99.83) Submitted: 10/17/2016 6:34:08 AM : Outperform Start Price: $2.39 NASDAQ:PSDV Score: -82.85

pSivida has fallen off a cliff since the last earnings call in August, probably because the timeline of regulatory submissions for Medidur has been pushed back once again. With a market cap of 80M and cash of 29M there's still room to fall so we won't be fleshing out the small zzporte position here. However, this could be an interesting pick up if it continues to drop before results of the second Medidur phase III trial in the second half of 2017.

Recs

0
Member Avatar 10qdetective (< 20) Submitted: 9/23/2014 4:58:43 PM : Outperform Start Price: $4.18 NASDAQ:PSDV Score: -115.44

Fiscal 4Q14 should provide some updates on Tethadur's development and with Iluvien's PDUFA coming on September 26th now is the appropriate time to enter for long term growth.

Recs

0
Member Avatar ptanabe (< 20) Submitted: 7/31/2013 6:46:35 PM : Outperform Start Price: $3.77 NASDAQ:PSDV Score: -137.50

k

Leaderboard

Find the members with the highest scoring picks in PSDV.

Score Leader

KidJones

KidJones (34.61) Score: +215.00

The Score Leader is the player with the highest score across all their picks in PSDV.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
casmar5501 92.55 4/4/2007 Underperform NS $10.08 -87.90% +112.41% +200.31 0 Comment
Ernbo6 53.20 4/9/2007 10/3/2008 Underperform 1Y $7.64 -84.03% +111.05% +195.08 1 Comment
bluebare 35.12 6/14/2013 Underperform 5Y $3.38 -63.91% +77.16% +141.06 0 Comment
bullshiite 29.27 3/12/2012 Underperform 5Y $1.76 -30.68% +109.92% +140.60 0 Comment
KidJones 34.61 4/16/2013 Underperform 5Y $2.27 -46.26% +84.75% +131.01 0 Comment
GrandfatherStock 98.45 3/25/2013 Underperform 5Y $2.15 -43.26% +85.24% +128.49 0 Comment
mytrendalert < 20 3/25/2013 Underperform 3M $2.12 -42.45% +85.08% +127.54 0 Comment
MMCapitalMgmt 99.93 4/17/2014 Underperform 5Y $3.49 -65.04% +55.34% +120.39 0 Comment
hicksjmu567 80.12 10/29/2013 Underperform 5Y $2.60 -53.08% +63.25% +116.32 0 Comment
IdahoInvestor 39.66 1/8/2013 Underperform 5Y $1.37 -10.95% +98.17% +109.12 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackLadenburg < 20 4/10/2013 Outperform NS $2.30 -46.96% +83.72% -130.67 0 Comment